Literature DB >> 11340382

Biodegradable polymers for ocular drug delivery.

H Kimura1, Y Ogura.   

Abstract

A variety of ocular drug delivery systems, including a controlled release of the drug, drug targeting, and penetration enhancement of the drug, have been investigated. Biodegradable polymers have been widely used as the drug carrier for controlled-release systems. Biodegradable polymers release the drug as they themselves degrade and are finally absorbed within the body. Several ocular drug delivery systems using different kinds of biodegradable polymers have been studied. In this article, we describe the fundamental mechanisms of drug delivery systems, polymer erosion and drug release, and then review those systems using the most popular biodegradable polymers, poly(lactic acid) and poly(lactic-glycolic acid). Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11340382     DOI: 10.1159/000050849

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  18 in total

Review 1.  Biodegradable implants for sustained drug release in the eye.

Authors:  Susan S Lee; Patrick Hughes; Aron D Ross; Michael R Robinson
Journal:  Pharm Res       Date:  2010-06-10       Impact factor: 4.200

2.  Impacts of nanomedicines in ocular pharmacotherapy.

Authors:  Ailar Nakhlband; Jaleh Barar
Journal:  Bioimpacts       Date:  2011-06-09

3.  Analytical and Computational Modeling of Sustained-Release Drug Implants in the Vitreous Humor.

Authors:  Anahid Khoobyar; Amin Naghdloo; Anita N Penkova; Mark S Humayun; Satwindar Singh Sadhal
Journal:  J Heat Transfer       Date:  2021-09-08       Impact factor: 1.855

4.  Development of sustained-release microspheres for the delivery of SAR 1118, an LFA-1 antagonist intended for the treatment of vascular complications of the eye.

Authors:  Sarath Yandrapu; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-20       Impact factor: 2.671

5.  Effect of the macromolecular architecture of biodegradable polyurethanes on the controlled delivery of ocular drugs.

Authors:  Gisele Rodrigues da Silva; Armando da Silva Cunha; Eliane Ayres; Rodrigo L Oréfice
Journal:  J Mater Sci Mater Med       Date:  2008-10-14       Impact factor: 3.896

Review 6.  Ocular delivery of macromolecules.

Authors:  Yoo Chun Kim; Bryce Chiang; Xianggen Wu; Mark R Prausnitz
Journal:  J Control Release       Date:  2014-07-03       Impact factor: 9.776

7.  Intravitreal Poly(L-lactide) Microparticles Sustain Retinal and Choroidal Delivery of TG-0054, a Hydrophilic Drug Intended for Neovascular Diseases.

Authors:  Namdev B Shelke; Rajendra Kadam; Puneet Tyagi; Vidhya R Rao; Uday B Kompella
Journal:  Drug Deliv Transl Res       Date:  2011-02       Impact factor: 4.617

Review 8.  Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications.

Authors:  Blake A Booth; Lori Vidal Denham; Saadallah Bouhanik; Jean T Jacob; James M Hill
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

9.  Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.

Authors:  Patrick J Marsac; Tonglei Li; Lynne S Taylor
Journal:  Pharm Res       Date:  2008-09-09       Impact factor: 4.200

10.  28-day intraocular pressure reduction with a single dose of brimonidine tartrate-loaded microspheres.

Authors:  Morgan V Fedorchak; Ian P Conner; Carlos A Medina; Jeremy B Wingard; Joel S Schuman; Steven R Little
Journal:  Exp Eye Res       Date:  2014-06-28       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.